A combination therapy pairing a small molecule inhibitor with monoclonal antibody immunotherapy improved patient outcomes for relapsed chronic lymphocytic leukemia, according to a Northwestern Medicine clinical trial.
Browsing: Clinical Breakthroughs
A novel therapy developed by Northwestern Medicine investigators improved progression-free and overall survival for patients with newly diagnosed malignant gliomas, the most common primary brain tumors in adults.
A targeted virtual health intervention was effective in reducing fear of recurrence among breast cancer survivors.
Measuring levels of hypervigilance and anxiety may improve healthcare providers’ understanding of severe esophageal diseases and treatment strategies, according to a Northwestern Medicine study.
Using universal myeloid progenitor cells or modified umbilical cord blood may help prevent infections in patients with leukemia, according to a pair of recent studies.
Children born to women with epilepsy who took anti-seizure medications during pregnancy versus children born to women without epilepsy did not differ in terms of cognitive outcomes and overall neurodevelopment, according to findings published in JAMA Neurology.
A new project led by Northwestern Medicine investigators aims to mitigate food deserts and kidney disease in predominantly Black communities in Chicago.
A Northwestern Medicine study has found that women with hormone receptor-positive breast cancer were more likely to discontinue hormone therapy early due to poor quality of life-related outcomes.
A growing cadre of Northwestern Medicine scientists are ensuring that evidence-based practices are put to use properly, a field that has taken on new urgency this year as the COVID-19 pandemic has exacerbated serious health disparities.